ABEL trial: A phase II randomized trial adding bemiparin (B) to chemo-radiotherapy (CT-RT) in limited-stage small cell lung cancer (SCLC)—Final results.
Bartomeu Massuti
No relevant relationships to disclose
Ramon Lecumberri
No relevant relationships to disclose
Guillermo M Lopez Vivanco
No relevant relationships to disclose
Albert Font
No relevant relationships to disclose
Enrique Gonzalez-Billalabeitia
No relevant relationships to disclose
Juan Luis Marti-Ciriquian
No relevant relationships to disclose
Jose Gómez-Codina
No relevant relationships to disclose
Manuel Domine
No relevant relationships to disclose
Isabel Bover
No relevant relationships to disclose
Dolores Isla
No relevant relationships to disclose
Antonio Galan
No relevant relationships to disclose
Alfonso Gurpide
No relevant relationships to disclose
Vicente Vicente
No relevant relationships to disclose
Rafael Rosell
No relevant relationships to disclose
Mayte Monreal
Employment or Leadership Position - Laboratorio Farmaceutico Rovi
Eduardo Rocha
Research Funding - Laboratorios Farmaceuticos Rovi